BIOCRYST PHARMACEUTICALS INC - BCRX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$2.584B

QoQ value delta ($000)

+$907.2M (+54.11%)

Implied price effect (QoQ)

+19.93%

Total shares

276,315,301

QoQ shares delta

+61,292,798 (+28.51%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 301 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	215,637	22,650,988	0.0%
VANGUARD GROUP INC	173,732	22,273,375	0.0%
RA CAPITAL MANAGEMENT, L.P.	150,674	15,827,186	1.6%
DEERFIELD MANAGEMENT COMPANY, L.P.	143,161	15,038,000	1.69%
STATE STREET CORP	116,223	12,208,360	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	107,048	11,244,625	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	106,012	11,135,762	0.0%
TCG Crossover Management, LLC	104,919	11,020,968	3.0%
JANUS HENDERSON GROUP PLC	84,853	8,908,506	0.04%
PERCEPTIVE ADVISORS LLC	70,771	7,434,033	1.38%
Vestal Point Capital, LP	66,878	7,025,000	1.87%
TWO SIGMA INVESTMENTS, LP	60,857	6,392,628	0.05%
GEODE CAPITAL MANAGEMENT, LLC	55,063	5,782,776	0.0%
Kynam Capital Management, LP	54,081	5,680,795	3.34%
BANK OF AMERICA CORP /DE/	48,473	5,091,765	0.0%
Aberdeen Group plc	47,987	5,040,670	0.08%
UBS Group AG	47,066	4,943,994	0.01%
Frazier Life Sciences Management, L.P.	38,167	4,009,240	0.98%
Royalty Pharma Sub-Manager, LLC	36,615	3,846,154	21.19%
Nuveen, LLC	36,359	3,819,263	0.01%
TWO SIGMA ADVISERS, LP	31,895	4,089,112	0.06%
GW&K Investment Management, LLC	30,850	3,240,462	0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	30,004	3,151,704	0.0%
Eversept Partners, LP	28,939	3,039,820	1.53%
RFG Advisory, LLC	27,329	2,870,700	0.5%